Frazier Life Sciences Acquisition Corp. II Announces Completion of $75,000,000 Initial Public Offering
Frazier Life Sciences Acquisition Corp. II closed its $75 million IPO of 7.5 million Class A ordinary shares at $10.00 each, now trading on Nasdaq under ticker FLSC since October 14, 2026. The SPAC is sponsored by a Frazier Life Sciences affiliate and led by CEO Albert Cha, with Jefferies as sole book-runner; it will search for biotechnology-sector business combinations.
Key figures
- Deal Value Usd
- 75000000
- Offering Price
- 10
- Shares Offered
- 7500000
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.